# Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

> **NCT04013685** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Orca Biosystems, Inc.** · enrollment: 255 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Myelodysplastic Syndromes
- Acute Leukemia
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Chronic Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** Orca-T

## Key facts

- **NCT ID:** NCT04013685
- **Lead sponsor:** Orca Biosystems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-21
- **Primary completion:** 2025-04-30
- **Final completion:** 2027-04
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04013685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04013685, "Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04013685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*